<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347940">
  <stage>Registered</stage>
  <submitdate>12/01/2012</submitdate>
  <approvaldate>13/01/2012</approvaldate>
  <actrnumber>ACTRN12612000070831</actrnumber>
  <trial_identification>
    <studytitle>The effects of minor electrical brain stimulation on everyday attention</studytitle>
    <scientifictitle>In healthy volunteers is active Transcranial Direct Current Stimulation (tDCS) better than sham stimulation at increasing scores on the Test of Everyday Attention (TEA)?</scientifictitle>
    <utrn>U1111-1127-0739</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Everyday attention</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will undergo one session of Transcranial Direct Current Stimulation (tDCS).  During this session, 2 mA of tDCS will be applied for 25 minutes over the right medial prefrontal cortex.  Each sponge electrode will be 9 cm2. The position of the electrodes will be defined as:

Primary Electrode: We will place the primary electrode over the right mPFC as identified by the junction of FP2, FZ, and F4 electrode positions of the 10/20 EEG electrode system.  10 participants will receive positive electrode stimulation, 10 will receive negative electrode stimulation, and 10 will receive no stimulation.  Participants who receive no stimulation will still have the primary electrode applied to the scalp, however, stimulation will only last for 10-seconds: just long enough to generate a slight tingle and blind the subject to his/her condition.

Secondary Electrode:  We will place the secondary electrode over the left primary motor cortex (M1) as identified by the C3 electrode position of the 10/20 electrode system.</interventions>
    <comparator>Sham Stimulation (same set up with no current moving between electrodes).</comparator>
    <control>Placebo</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Standardized scores on the Test of Everyday Attention (TEA).</outcome>
      <timepoint>Pre-stimulation
Immediately following stimulation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy Volunteer</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>No presence of the following:
Personal history of epilepsy, head trauma, or neurological illness
History of deep brain stimulation or ablation surgery
Presence of large mass brain lesions
History of schizophrenia, schizoaffective disorder, or rapid-cycling bipolar illness
Cranial metal implants
Medical pump or cardiac pacemaker implants
Actual or possible pregnancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>This protocol will be double-blind.  Neither the participant nor investigator will know which condition each participant is in.  Although the lead investigator will set up the tDCS device, a second investigator (unblind) will actually turn on/off the device thereby leaving the lead investigator blind.   A 39 number randomization list has been compiled using MatLab (to account for possible participant drop outs) and will be followed in order as subjects enroll.</concealment>
    <sequence>Randomized list compiled using a computer program.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/02/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Melbourne</primarysponsorname>
    <primarysponsoraddress>UoM
VIC-3010</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Unfunded</fundingname>
      <fundingaddress>Nil</fundingaddress>
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In this study, we hope to examine tDCS effects on global arousal and attention levels.  Combining evidence gathered from animal models, psychological models, pharmaceutical research, and neurostimulatory research - we hope not only to better elucidate the overall arousal/attention correlation, but also to determine if noninvasive brain-modulation can produce effects comparable to certain drug classes.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>13/01/2012</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jared Horvath</name>
      <address>University of Melbourne
Redmond Barry Building
Rm. 809
VIC - 3010</address>
      <phone>+61 (0)432466963</phone>
      <fax />
      <email>jhorvath@student.unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jared Horvath</name>
      <address>University of Melbourne
Redmond Barry Building
Rm. 809
VIC - 3010</address>
      <phone>+61 (0)432466963</phone>
      <fax />
      <email>jhorvath@student.unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>